Benevolent AI (Benevolent AI) Operating Cash Flow per Share : $-0.61 (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Benevolent AI Operating Cash Flow per Share?

Benevolent AI's operating cash flow per share for the three months ended in Dec. 2023 was $-0.12. Benevolent AI's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.61.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -28.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -23.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Benevolent AI's Operating Cash Flow per Share or its related term are showing as below:

BAIVF' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -51.1 Med: -28.2 Max: -11
Current: -28.2

During the past 6 years, Benevolent AI's highest 3-Year average Operating Cash Flow per Share Growth Rate was -11.00% per year. The lowest was -51.10% per year. And the median was -28.20% per year.

BAIVF's 3-Year OCF Growth Rate is ranked worse than
80.13% of 1233 companies
in the Biotechnology industry
Industry Median: 3.3 vs BAIVF: -28.20

Benevolent AI Operating Cash Flow per Share Historical Data

The historical data trend for Benevolent AI's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI Operating Cash Flow per Share Chart

Benevolent AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.26

-0.32

-0.45

-0.86

-0.61

Benevolent AI Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial				-	-0.52	-0.39	-0.49	-0.12

Competitive Comparison of Benevolent AI's Operating Cash Flow per Share

For the Biotechnology subindustry, Benevolent AI's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Benevolent AI's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benevolent AI's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Benevolent AI's Price-to-Operating-Cash-Flow falls into.

Benevolent AI Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Benevolent AI's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-72.309	/	118.308
	=	-0.61

Benevolent AI's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-14.596	/	118.308
	=	-0.12

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.61

Benevolent AI Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Benevolent AI's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Benevolent AI (Benevolent AI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (GREY:BAIVF) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

BAI:Netherlands 2XA:Germany

Address

4-8 Maple Street, London, GBR, W1T 5HD

Website

https://www.benevolent.com

Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.